Alison Luckey

Global Antibiotic Research & Development Partnership

Publishes on Reproductive tract infections research, Antibiotic Resistance in Bacteria, Bacterial Infections and Vaccines. 21 papers and 4k citations.

PubIndex Score68Top 32% · mid-careerHow it's scored

21Publications

4kTotal Citations

First publication: 2013First senior author: 2023

Reproductive tract infections research Antibiotic Resistance in Bacteria Bacterial Infections and Vaccines Antibiotics Pharmacokinetics and Efficacy Antibiotic Use and Resistance

Top publicationsby citations

Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study

Oliver A. Cornely, Sílvia Gómez-Zorrilla, Angela Cano Yuste et al.|Journal of Antimicrobial Chemotherapy|2019

Cited by 123

Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial

Yehuda Carmeli, Surbhi Malhotra‐Kumar, José Miguel Cisneros et al.|The Lancet Infectious Diseases|2024

Cited by 98

Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation

Shampa Das, Susan Raber, Todd Riccobene et al.|European Journal of Clinical Pharmacology|2024

Cited by 28

Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial

Alison Luckey, Manica Balasegaram, Lindley A. Barbee et al.|The Lancet|2025

Cited by 26

2893 A. Efficacy and Safety of Aztreonam-Avibactam for the Treatment of Serious Infections Due to Gram-Negative Bacteria, Including Metallo-β-Lactamase-Producing Pathogens: Phase 3 REVISIT Study

Yehuda Carmeli, Joseph W. Chow, Jose-Miguel Cisneros et al.|Open Forum Infectious Diseases|2023

Cited by 25